Price cuts and the dynamics of the EU market
This article was originally published in Scrip
Executive Summary
The protests against Greek price cuts reported this week are just the latest skirmishes in the unending feud between industry and EU governments over pharmaceutical pricing policies. And disagreements over the extent to which these latest cuts will affect the dynamics of the European pharmaceutical market show how difficult it is to predict the knock-on effects of price changes from one country to another.